aflibercept Injection [Eylea]
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
BACKGROUND
In the treatment of center-involving diabetic macular edema, despite initial therapy with an anti-VEGF compound, an…
Introduction . Age-related macular degeneration is a leading cause of severe vision loss worldwide, frequently resulting in legal…
The aim of the report is to evaluate the short-term efficacy and safety of aflibercept (EYLEA®) in patients with choroidal…
© Touch MEdical MEdia 2014 Abstract A satellite symposium entitled ‘Aflibercept* – Setting Its Sights On Diabetic Macular Oedema…